MITCHELDEAN SURGERY — All Prescriptions & Medications — Page 6
Practice Code: L84045 | MITCHELDEAN, GL17 0AU
Showing results 251-300 of 612
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Etoricoxib | 94 | 2,141 | £576 | +16.7% ▲ |
| Aripiprazole | 93 | 1,257 | £168 | -63.5% ▼ |
| 93 | 4,230 | £17.0K | +105.7% ▲ | |
| Nicotine | 92 | 4,150 | £1.8K | +62.9% ▲ |
| Baclofen | 91 | 31.7K | £661 | -54.6% ▼ |
| Haloperidol | 90 | 2,720 | £1.6K | +89.0% ▲ |
| Lisdexamfetamine dimesylate | 90 | 2,576 | £6.1K | -24.6% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 90 | 189.4K | £1.9K | +380.7% ▲ |
| Chlorphenamine maleate | 89 | 3,186 | £91 | -19.4% ▼ |
| Levomepromazine hydrochloride | 88 | 610 | £1.2K | +282.2% ▲ |
| Phenytoin sodium | 88 | 4,018 | £630 | +9.0% ▲ |
| Nebivolol | 87 | 2,478 | £512 | -17.9% ▼ |
| 87 | 10.2K | £408 | -33.6% ▼ | |
| Disulfiram | 86 | 1,232 | £4.3K | +480.8% ▲ |
| Carbimazole | 86 | 3,642 | £187 | -23.9% ▼ |
| Neomycin sulfate | 86 | 1,350 | £169 | +45.1% ▲ |
| Oxybutynin | 85 | 4,452 | £89 | -55.4% ▼ |
| Fusidic acid | 84 | 1,515 | £193 | -34.2% ▼ |
| Metronidazole | 83 | 2,528 | £798 | +26.3% ▲ |
| 83 | 830 | £2.1K | +605.8% ▲ | |
| Tamoxifen citrate | 82 | 2,333 | £187 | -0.4% vs avg |
| Brinzolamide | 81 | 585 | £434 | -37.7% ▼ |
| Glycopyrronium bromide | 81 | 493 | £804 | +239.9% ▲ |
| Metoprolol tartrate | 80 | 2,296 | £1.1K | +57.7% ▲ |
| Olmesartan medoxomil | 80 | 2,240 | £82 | +16.1% ▲ |
| Nystatin | 80 | 2,550 | £145 | -20.6% ▼ |
| Lofepramine hydrochloride | 79 | 2,282 | £938 | +164.1% ▲ |
| Cefalexin | 79 | 2,647 | £191 | -32.1% ▼ |
| Azithromycin | 79 | 1,548 | £502 | -37.7% ▼ |
| 79 | 450 | £1.2K | +226.1% ▲ | |
| Desloratadine | 78 | 4,535 | £419 | +170.4% ▲ |
| 78 | 6,790 | £390 | +11.8% ▲ | |
| Rizatriptan | 77 | 560 | £1.1K | +29.5% ▲ |
| Benzydamine hydrochloride | 76 | 7,410 | £186 | -1.7% vs avg |
| Powder extensively hydrolysed formula (0913101) | 75 | 176.4K | £4.9K | +4.1% ▲ |
| 75 | 1,998 | £4.0K | +130.2% ▲ | |
| 75 | 11.1K | £1.0K | -84.2% ▼ | |
| Moxonidine | 73 | 1,960 | £277 | +31.1% ▲ |
| Rasagiline mesilate | 73 | 805 | £597 | +96.5% ▲ |
| Triptorelin | 72 | 72 | £13.5K | +241.4% ▲ |
| Insulin degludec | 71 | 390 | £3.5K | -35.4% ▼ |
| Alfuzosin hydrochloride | 70 | 3,146 | £646 | -2.1% ▼ |
| Exemestane | 70 | 2,100 | £384 | +115.4% ▲ |
| Sotalol hydrochloride | 68 | 2,688 | £92 | -3.3% ▼ |
| Tranexamic acid | 68 | 4,038 | £266 | -19.8% ▼ |
| Dosulepin hydrochloride | 68 | 4,116 | £865 | +20.1% ▲ |
| Clonazepam | 68 | 3,919 | £552 | -56.4% ▼ |
| Testosterone | 68 | 4,736 | £2.4K | -10.9% ▼ |
| Calcipotriol | 68 | 4,950 | £2.6K | -60.1% ▼ |
| Irbesartan | 67 | 700 | £37 | -72.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.